Loading

Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.46439/cardiology.3.023

Investigation of cardiac pacemaker channel HCN4 leads to new therapeutic approaches in the treatment of viral diseases associated with bradycardia/ cardiac arrest

  • #Contributes similarly to this study
  • 1Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, D-48149 Münster, Germany
+ Affiliations - Affiliations

Corresponding Author

Stefan Peischard, stefan.peischard@ukmuenster.de

Received Date: August 02, 2023

Accepted Date: August 14, 2023

Abstract

Virus infections represent a serious threat for human health, causing immense costs and burdens for health systems. Viral diseases and their treatment are therefore of global interest, that extensively increased with the beginning of the SARS-CoV-2 pandemic at the end of 2019. About one third of myocarditis cases originate in infections caused by the enterovirus Coxsackievirus B3 (CVB3). The effects of CVB3 on the human pacemaker have been studied in detail. In human induced pluripotent stem cell derived pacemaker like cells, the pacemaker ion channel (HCN4) location has been found to be switched from membranous, to autophagosomal in a Rab7 dependant manner. Two CVB3 proteins have been of special interest, one being highly conserved in enteroviruses (CVB3 2C). Understanding of the CVB3 infection mechanism is therefore beneficial for the development of antiviral therapies and antiviral drugs. Additionally, the found mechanisms might potentially be transferable on other enteroviruses, providing therapy options for enteroviruses in general.

Keywords

Heart disease, Sinoatrial node, HCN4, Enterovirus, Coxsackievirus, Rab, GTPase

Author Information X